Showing results (211-220 of 335) with videos related to
Sort By:
Pageof 34
Cancer Research|October 22, 2020
RIG-I-Like Receptor LGP2 Is Required for Tumor Control by RadiotherapyWenxin Zheng, Diana Rose E Ranoa, Xiaona Huang, et al.Science Immunology|May 16, 2025
ILC3s promote intestinal tuft cell hyperplasia and anthelmintic immunity through RANK signalingHongkai Xu, Yibo Wang, Wenyan Wang, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastasesPing Yu, Youjin Lee, Yang Wang, et al.The Journal of Experimental Medicine|March 7, 2020
Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signalingYaoyao Shi, Wenxin Zheng, Kaiting Yang, et al.Cell Reports. Medicine|May 2, 2022
AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cellsHuiyu Li, Zhida Liu, Longchao Liu, et al.Nature Cell Biology|December 6, 2022
IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8+ T cells to overcome immunotherapy resistance in cancerJoonbeom Bae, Longchao Liu, Casey Moore, et al.The Journal of Clinical Investigation|April 7, 2004
Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathyJing Wang, Robert A Anders, Qiang Wu, et al.Plos One|February 8, 2014
Tolerogenic properties of lymphatic endothelial cells are controlled by the lymph node microenvironmentJarish N Cohen, Eric F Tewalt, Sherin J Rouhani, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
Lymphotoxin pathway-directed, autoimmune regulator-independent central tolerance to arthritogenic collagenRobert K Chin, Mingzhao Zhu, Peter A Christiansen, et al.Nature Communications|September 15, 2015
GITR subverts Foxp3(+) Tregs to boost Th9 immunity through regulation of histone acetylationXiang Xiao, Xiaomin Shi, Yihui Fan, et al.Pageof 34